Literature DB >> 17406166

Case files from Stanford University Medical Center: Drug resistance testing in previously untreated patients with HIV--knowing what to look for and choosing appropriate therapy.

Robert W Shafer1, Dong Phuong Nguyen, W Jeffrey Fessel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17406166      PMCID： PMC1781271     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  20 in total

1.  Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy.

Authors:  C F Perno; A Cozzi-Lepri; C Balotta; F Forbici; M Violin; A Bertoli; G Facchi; P Pezzotti; G Angarano; C Arici; P Narciso; A Orani; E Raise; A Scalzini; A Poggio; G Ippolito; M Moroni; A D Monforte
Journal:  Antivir Ther       Date:  2001-09

2.  Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons.

Authors:  J G Garcia-Lerma; S Nidtha; K Blumoff; H Weinstock; W Heneine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection.

Authors:  Bluma G Brenner; Jean-Pierre Routy; Marco Petrella; Daniela Moisi; Maureen Oliveira; Mervi Detorio; Bonnie Spira; Vidal Essabag; Brian Conway; Richard Lalonde; Rafick-Pierre Sekaly; Mark A Wainberg
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus.

Authors:  A de Ronde; M van Dooren; L van Der Hoek; D Bouwhuis; E de Rooij; B van Gemen; R de Boer; J Goudsmit
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy.

Authors:  C F Perno; A Cozzi-Lepri; C Balotta; F Forbici; M Violin; A Bertoli; G Facchi; P Pezzotti; G Cadeo; G Tositti; S Pasquinucci; S Pauluzzi; A Scalzini; B Salassa; A Vincenti; A N Phillips; F Dianzani; A Appice; G Angarano; L Monno; G Ippolito; M Moroni; A d' Arminio Monforte
Journal:  J Infect Dis       Date:  2001-08-30       Impact factor: 5.226

6.  Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.

Authors:  Vincent Le Moing; Rodolphe Thiébaut; Geneviève Chêne; Catherine Leport; Valérie Cailleton; Christian Michelet; Hervé Fleury; Serge Herson; François Raffi
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

7.  CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Authors:  Gilbert R Kaufmann; Luc Perrin; Guiseppe Pantaleo; Milos Opravil; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; Bruno Ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Matthias Egger; Manuel Battegay
Journal:  Arch Intern Med       Date:  2003-10-13

8.  Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.

Authors:  Gregory K Robbins; Victor De Gruttola; Robert W Shafer; Laura M Smeaton; Sally W Snyder; Carla Pettinelli; Michael P Dubé; Margaret A Fischl; Richard B Pollard; Robert Delapenha; Linda Gedeon; Charles van der Horst; Robert L Murphy; Mark I Becker; Richard T D'Aquila; Stefano Vella; Thomas C Merigan; Martin S Hirsch
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

9.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks
Journal:  J Infect Dis       Date:  2003-04-23       Impact factor: 5.226

10.  Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression.

Authors:  Fernando Dronda; Santiago Moreno; Ana Moreno; José L Casado; María J Pérez-Elías; Antonio Antela
Journal:  Clin Infect Dis       Date:  2002-09-25       Impact factor: 9.079
View more
  1 in total

1.  HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme.

Authors:  Catherine Orrell; Rochelle P Walensky; Elena Losina; Jennifer Pitt; Kenneth A Freedberg; Robin Wood
Journal:  Antivir Ther       Date:  2009
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.